This is a routine, post-vesting sale of RSUs by a non-executive director and not indicative of broader insider concern. Traders should monitor for additional Form 144s or Form 4s to assess whether this is part of a larger selling pattern.
Price Chart
Executive Summary
Robert C. Malenka, a director of MapLight Therapeutics, filed a Form 144 notifying intent to sell 8,593 shares of common stock, representing a small portion of his holdings. The shares are restricted stock units that became vested on April 1, 2026, and are proposed for sale on the NASDAQ.
Key Facts
- Reporting person: Robert C. Malenka, Director of MapLight Therapeutics
- Proposed sale: 8,593 shares of common stock
- Shares are from restricted stock units (RSUs) that vested on April 1, 2026
- Filing date: April 15, 2026
- Shares to be sold on NASDAQ
Financial Impact
Approximately $232,183 based on a $26.99 share price at filing date (calculated from $232,182.86 total value disclosed)
Risk Factors
- Perception of insider selling, though minimal given director role and small volume
- Potential downward pressure on stock if sale is executed near-term
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001950047-26-003510 |
| Document: 0001950047-26-003510-index.html | 0001950047-26-003510 |
| Document: 0001950047-26-003510.txt | 0001950047-26-003510 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 16, 2026 10d ago | Insider Cluster | $8.00 | awaiting T+20 | — | $7.74 (+3.25%) |
Oct 15, 2026 11d ago | 144 | $7.70 | awaiting T+20 | — | $7.74 (+0.52%) |
Oct 15, 2026 11d ago | 144 | $7.70 | awaiting T+20 | — | $7.74 (+0.52%) |
Oct 15, 2026 11d ago | 144 | $7.70 | awaiting T+20 | — | $7.74 (+0.52%) |
Sep 24, 2026 4w ago | EFFECT | $10.76 $8.25 | ▼ −23.33% | ▼ −22.91% | $7.74 (−28.07%) |
Sep 18, 2026 5w ago | S-1/A | $10.90 $8.00 | ▼ −26.61% | ▼ −25.70% | $7.74 (−28.99%) |
Aug 4, 2026 11w ago | Insider Cluster | $12.92 $13.06 | ▲ +1.08% | ▲ +1.69% | $7.74 (−40.09%) |
Aug 3, 2026 12w ago | 144 | $12.94 $13.31 | ▲ +2.86% | ▲ +4.10% | $7.74 (−40.19%) |
Jul 30, 2026 12w ago | 144 | $13.02 $12.60 | ▲ +3.23% | ▲ +6.21% | $7.74 (+40.55%) |
Jul 28, 2026 12w ago | Insider Buy | $15.02 $12.86 | ▼ −14.38% | ▼ −19.40% | $7.74 (−48.47%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers